VivaGel(R) Demonstrates Anti-HIV and Herpes Activity Following Human Administration

... MELBOURNE, Australia, Aug. 4 /PRNewswire-FirstCall/ -- starpharma Holdings Limited (ASX: SPL, OTCQX: SPHRY) today announced the results of its clinical trial demonstrating that VivaGel(R) retains antiviral activity a...

Starpharma and Elanco Sign Agreement

... MELBOURNE, Australia, May 11 /PRNewswire/ -- starpharma Holdings Limited (ASX:SPL, OTCQX:SPHRY) today anno...harma's dendrimer technology. Under the agreement, starpharma will receive revenue from research fees, and is el...otential applications of its dendrimer technology. starpharma also has partnerships with SSL International (Dure...

FDA Warning for N-9 - an Opportunity for VivaGel(R)

...selves from infection with these serious diseases. starpharma is intent on developing VivaGel(R), both as a stan...HRMS/DOCKETS/98fr/07-6111.htm About Starpharma starpharma Holdings Limited (ASX:SPL, OTCQX:SPHRY) is a world...s principally composed of two operating companies, starpharma Pty Ltd in Melbourne, Australia and Dendritic Nano...

Starpharma and Durex Sign Co-Development Agreement for VivaGel(R)-Coated Condoms

...ivaGel(R) coating. Undisclosed fees are payable to starpharma under the co-development agreement, which also pro...l position and the strength of the Durex(R) brand, starpharma also values the organisation's innovative approach... two unrelated condom coating agreements signed by starpharma in the last three months," concluded Dr. Fairley. ...

Starpharma Develops New Gel (Vivagel) To Prevent HIV Transmission

... The pharmaceutical company starpharma saw an 8% increase in its share, following approval of Vivagel by the FDA, a new formulation, believed to prevent transmission of HIV. // The company...

Starpharma in Biological News

UCSF study will test new vaginal microbicide for herpes and HIV

... If she were a sex worker it could be several times a day," she said. The study is being conducted in collaboration with the gel’s manufacturer, starpharma Holdings, Ltd., of Melbourne, Australia, and is being underwritten by the Sexually Transmitted Infection Clinical Trials Group, which is funded in par...

Starpharma in Biological Technology

World Nanomedicine Market to Cross $160 Billion by 2015, According to New Report by Global Industry Analysts, Inc.

...armaceuticals Inc., Life Technologies Corporation, Nanosphere Inc., Nektar Therapeutics, Novavax Inc., Oxonica Plc, Par Pharmaceutical Companies Inc., starpharma Holdings Limited, and Wyeth Pharmaceuticals Inc., among others. The report titled "Nanomedicine: A Global Strategic Business Report" ann...